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Abstract 
Objective: To make a recommendation on the “best” instrument to assess attitudes toward 
and/or capabilities regarding self-management of osteoarthritis based on available 
measurement property evidence. 
Methods: Electronic searches were performed in MEDLINE, EMBASE, CINAHL and PsychINFO  
(inception to 27 December 2016). Two reviewers independently rated measurement properties 
using the Consensus-based Standards for the selection of Health Measurement Instruments 
(COSMIN) 4-point scale. Best evidence synthesis was determined by considering COSMIN 
ratings for measurement property results and the level of evidence available for each 
measurement property of each instrument. 
Results: Eight studies out of 5653 publications met the inclusion criteria, with eight instruments 
identified for evaluation: Multidimensional Health Locus of Control, Perceived Behavioural 
Control, Patient Activation Measure, Educational Needs Assessment, Stages of Change 
Questionnaire in Osteoarthritis, Effective Consumer Scale and Perceived Efficacy in Patient–
Physician Interactions five item (PEPPI-5) and ten item scales. Measurement properties 
assessed for these instruments included internal consistency (k=8), structural validity (k=8), 
test-retest reliability (k=2), measurement error (k=1), hypothesis testing (k=3) and cross-cultural 
validity (k=3). No information was available for content validity, responsiveness or minimal 
important change/difference. The Dutch PEPPI-5 demonstrated the best measurement 
property evidence; strong evidence for internal consistency and structural validity but limited 
evidence for reliability and construct validity.  
Conclusion: Although PEPPI-5 was identified as having the best measurement properties, 
overall there is a poor level of evidence currently available concerning measurement properties 
of instruments to assess attitudes toward and/or capabilities regarding osteoarthritis self-
management. Further well-designed studies investigating measurement properties of existing 
instruments are required. 
 
Keywords: Self-management, instruments, measurement properties, psychometrics, 
clinimetrics, systematic review 
Running title: Self-management instrument review 
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 1 
Introduction 1 
Healthcare systems currently face a rising number of people living with chronic conditions 2 
leading to disability, without causing death [1]. The Chronic Care Model (CCM) has been 3 
promoted to assist healthcare systems to meet the escalating demands attributable to chronic 4 
conditions [2]. The CCM describes healthcare whereby patients are enabled to manage their 5 
condition supported by a proactive healthcare delivery system, involving a coordinated team of 6 
health professionals with the expertise required to provide decision support, all underpinned by 7 
appropriate health information systems [2]. Self-management programmes are interventions 8 
based on the tenets of the CCM; they aim to improve self-management capabilities. It follows 9 
that the efficacy of these programmes should be measured by assessing change in participants’ 10 
attitudes toward and/or capabilities to manage their health. However, there are few 11 
recommendations guiding which instruments accurately measure self-management [3]. The 12 
widespread heterogeneity in standardised instruments measuring self-management programs 13 
is surprising given that the primary aim of these programs is to directly influence the attitudes 14 
toward and abilities to manage one’s health. 15 
This situation is apparent in self-management programmes for osteoarthritis (OA). Research 16 
examining the efficacy of OA self-management programmes has focussed on measures of pain 17 
and function [4]. While these outcomes are obviously important to this population, there 18 
appears to be disparity in the aims of self-management programmes and the outcomes used to 19 
assess efficacy [5]. Self-management programs aim to provide participants with the necessary 20 
tools to manage their own condition rather than “cure” OA. Although these programmes may 21 
not dramatically reduce pain and enhance functional ability, this does not necessarily reflect a 22 
failed strategy if the participants improve their attitudes towards and ability to manage 23 
symptoms and live with an acceptable quality of life despite their disease [5].  24 
A systematic review reported low-to-moderate quality evidence of no or small benefits to 25 
participants of OA self-management education programmes [5]. The authors highlighted the 26 
heterogeneity of outcomes used to quantify the effects of self-management programmes and 27 
that work is needed to establish which outcomes are important to patients. This review 28 
recommended rigorous evaluation of OA self-management programmes with validated 29 
instruments fit to measure attitudes towards/capabilities to self-manage OA, and advised that 30 
to achieve this, the measurement properties of the existing instruments need further 31 
investigation [5].  32 
Measurement properties refer to the ability of the instrument to truthfully and 33 
comprehensively measure the specified construct [6]. In addition, it is necessary to 34 
demonstrate that the instrument is discriminative, sensitive, reliable and deemed feasible in 35 
terms of cost and time constraints [7]. It is important to consider that the measurement 36 
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properties of an instrument are not universal across different populations; hence, it cannot be 37 
assumed that one with good measurement properties in a specific population will demonstrate 38 
the same results in a different population [8]. Therefore, the measurement properties of an 39 
instrument must be considered within the specific context of the population of interest.  40 
The aims of this systematic review were to: i) identify studies reporting measurement 41 
properties of instruments assessing attitudes toward and/or capabilities regarding self-42 
management of OA; ii) systematically critique the studies evaluating instruments using the 43 
Consensus-based Standards for the selection of Health Measurement Instruments (COSMIN) 44 
tool: and iii) synthesize the evidence available with the possibility of making rudimentary 45 
recommendations concerning the best evidence-based instruments to assess attitudes toward 46 
and/or capabilities regarding self-management of OA.  47 
Methodology 48 
Terminology 49 
Self-management was defined as the individual’s ability to manage their physical and 50 
psychological symptoms, treatments, consequences and lifestyle changes required to live with 51 
their OA [9]. Attitudes toward and/or capabilities regarding self-management of OA included 52 
the following constructs: knowledge, skills, beliefs, behaviours, activation, self-efficacy, health 53 
locus of control, readiness to change healthcare behaviours, healthcare navigation, 54 
participation, engagement, and motivation. This list of possible constructs was developed a 55 
priori using existing content knowledge about available instruments of the authors, and new 56 
constructs identified during the review were also included. 57 
Review protocol 58 
The review protocol was developed in accordance with the Preferred Reporting Items for 59 
Systematic Reviews and Meta-Analyses (PRISMA) statement and prospectively registered with 60 
PROSPERO on 24 November 2015 (CRD42015019074). 61 
Literature search 62 
The review search strategy was developed and refined by the study authors according to the 63 
PRISMA statement and recommendations made for conducting systematic reviews of 64 
measurement properties [8, 10]. Electronic searches were conducted of the following four 65 
bibliographic databases from inception to 27 December 2016: MEDLINE (PubMed), EMBASE 66 
(OvidSP), CINAHL (Ebsco), PsychINFO (OvidSP). An initial search was conducted using four main 67 
filters containing key search terms as briefly summarised below (see Appendix 1  PubMed 68 
search strategy): 69 
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I. Construct- attitudes toward and capabilities regarding self-management of OA using terms 70 
such as: “self-treatment OR self-management OR patient education…” Names of known 71 
instruments measuring attitudes and/or capabilities regarding self-management were 72 
added using ‘OR’: “health education impact questionnaire OR patient activation measure 73 
OR effective consumer scale …”  74 
II. Target population- osteoarthritis OR osteoarth* OR degenerative arthritis OR arthrosis. 75 
III. Measurement instrument filter- designed for PubMed to retrieve more than 97% of 76 
publications related to measurement properties [11] using terms such as: “instrumentation 77 
OR methods OR validation studies…” The filter was translated into the language of the other 78 
databases used.  79 
IV. Exclusion filter- An exclusion filter was used to improve the precision of the measurement 80 
instrument filter [11]. 81 
Secondary searching was conducted for all instruments measuring attitudes toward and 82 
capabilities regarding self-management of OA identified during the initial search. The name of 83 
each instrument was used as the keyword combined (AND) with the target population filter in 84 
PubMed. Targeted hand searching of reference lists was also used. Results of the database 85 
searches were imported into Endnote X7 (Thomson Reuters, Philadelphia, USA). 86 
Eligibility criteria 87 
Study titles were screened by one reviewer (JE). Two reviewers (JE & SM) independently 88 
screened abstracts, followed by the full text of potentially eligible studies. Disagreements were 89 
discussed and resolved with a third reviewer (KM). Studies were included if they met the 90 
following criteria: 91 
1. Construct- at least one instrument attempted to measure the participants’ attitudes and/or 92 
capabilities regarding self-management of their OA.  93 
2. Target Population- adults diagnosed with any stage of OA according to American College of 94 
Rheumatology guidelines, clinical diagnosis of OA from examination findings, patients’ 95 
symptoms or radiographic evidence of disease. Studies with mixed disease populations 96 
were excluded if the proportion of participants with a main diagnosis of OA was less than 97 
80% and the results for OA participants were not reported separately. 98 
3. Measurement Instrument- patient-reported outcomes (PROs) (completed by the 99 
participant) in the form of questionnaires or scales.  100 
4. Measurement Properties- the study was required to explicitly state a primary or secondary 101 
aim to develop an instrument or examine at least one measurement property of the 102 
instrument involved. 103 
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5. Setting- the instrument was required to have been utilised in a clinic, field or community 104 
setting using readily available equipment. Instruments with a license fee were included.  105 
6. Publication type- full text studies published as original articles in peer-reviewed journals. 106 
7. Language- English language studies were included. Non-English language studies were 107 
noted and data extraction performed when possible, however these were excluded from 108 
COSMIN rating due to lack of access to translation resources, and the high level of detail 109 
required for a COSMIN review. 110 
Data extraction 111 
Two reviewers (JE & SM) independently extracted data to a predefined spreadsheet with a third 112 
reviewer (KM) available to resolve differences. The generalisability of the included studies was 113 
considered by extracting characteristics such as mean age, gender distribution, OA stage, 114 
setting and language. Relevant data regarding interpretability issues was extracted including 115 
distribution of scores, floor and ceiling effects, change scores, and minimal important change 116 
(MIC) or minimal important difference (MID) [12]. 117 
 118 
Methodological quality evaluation of the studies 119 
Two raters (JE & NC) independently assessed the methodological quality of the included 120 
studies, with a third rater (FD) available to resolve discrepancies. Included studies were 121 
assessed according to the COSMIN taxonomy of the following measurement properties: 122 
internal consistency, reliability, measurement error, content validity, structural validity, 123 
hypotheses testing (a form of construct validity), cross-cultural validity, and responsiveness 124 
[13]. The definitions of these measurement properties are summarised in Table 1 [12]. Each 125 
measurement property featured within a particular study was rated separately according to the 126 
COSMIN tool; a robust quality evaluation tool using a 4-point scoring system: “poor”, “fair”, 127 
“good” or “excellent” [12, 14] . An overall quality score was given for each measurement 128 
property in each study using the “worst score counts” method that accounted for the lowest 129 
rating of any item within that measurement property section [14].  130 
Evaluation of measurement property result 131 
An overall quality rating of the measurement property results for each instrument was 132 
performed using a checklist of criteria for good measurement properties [15](Appendix 2). Two 133 
raters determined the quality rating using this additional tool (JE & SM) with disagreements 134 
resolved with a third reviewer (NC).  135 
Data synthesis 136 
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Qualitative analysis: To summarise the level of evidence of each measurement property for 137 
each instrument, a “best evidence synthesis” was performed. The “best evidence synthesis” 138 
was derived by triangulating the methodological quality of the studies [12] (using the COSMIN 139 
score), the quality criteria for rating the results of measurement properties (Appendix 2) [15], 140 
and the level of evidence for the measurement properties of the instruments according to the 141 
following: “strong”, “moderate”, “limited”, “conflicting”, or “indeterminate” [8, 15]; (Table 2).  142 
Quantitative analysis: Meta-analysis of data was planned for studies of fair or better 143 
methodological quality and of sufficient homogeneity [8].  144 
Results 145 
The initial search strategy identified 5653 studies (Figure 1). Following title and abstract 146 
screening, 44 studies were identified for full-text review. Following full-text review, eight 147 
studies were included [16-23]. Each study assessed a different instrument, therefore it was not 148 
possible to pool data for quantitative analyses. 149 
The content of instruments varied widely with respect to the constructs of self-management 150 
they represented. Table 3 provides a content comparison of the constructs represented in the 151 
eight instruments, their characteristics are summarised in Table 4. The Patient Activation 152 
Measure (PAM) [16] required a license fee; all others were freely available online or following 153 
contact with the authors. Many instruments were translated into a language other the original, 154 
including Korean [16], Dutch [17, 20-22], Austrian-German, Finnish, Norwegian, Portuguese, 155 
Spanish, Swedish [20] and Chinese [23].  156 
 157 
Study characteristics such as cohort descriptors, sample sizes and instrument scores are 158 
provided in Table 4. The OA sites captured within the studies included hand, hip and knee [17, 159 
20], hip and knee [18], knee [23]or were not specified [16, 19, 21, 22]. Stage or duration of OA 160 
was generally unreported. Participants were predominantly female across all studies and 161 
representative of the age of the wider OA population, with mean age ranging from 62-72.2 162 
years.  163 
 164 
Measurement property results and “best evidence synthesis” 165 
 166 
Findings for measurement properties are summarised in Tables 5 and 6, qualitative data 167 
synthesis in Table 7.  168 
  169 
Internal Consistency 170 
Internal consistency was estimated for all instruments. Strong evidence (excellent rating) for 171 
internal consistency (Cronbach’s α = 0.92) was found for the Perceived Efficacy in Patient–172 
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Physician Interactions 5 item scale (PEPPI-5) [21], satisfying requirements for unidimensionality 173 
(Appendix 2). Moderate evidence (good rating) of adequate internal consistency was 174 
demonstrated for the Perceived Efficacy in Patient–Physician Interactions  10 item scale (PEPPI-175 
10) [23] (Cronbach’s α = 0.91). Limited evidence (fair rating) of adequate internal consistency 176 
was found for three instruments: Perceived Behavioural Control (PBC) [19], PAM-13 [16] and 177 
The Stages of Change Questionnaire in Osteoarthritis (SCQOA) [17]. There was indeterminate 178 
evidence (poor rating) of internal consistency for three instruments: Multidimensional Health 179 
Locus of Control (MHLC) (form C) [18], Educational Needs Assessment Tool (ENAT) [20] and 180 
Effective Consumer Scale (EC-17) [22]. 181 
 182 
Reliability 183 
Adequate test-retest reliability required intraclass correlation coefficient (ICC)> 0.7 (see 184 
Appendix 2). There was limited evidence (fair rating) of inadequate test-retest reliability for the 185 
PEPPI-5 (ICC= 0.68) [21]. Indeterminate evidence (poor rating) of adequate test-retest reliability 186 
was found for the EC-17 [22] (ICC= 0.71). 187 
 188 
Measurement error 189 
Although data for test-retest reliability can be used to calculate measurement error, only one 190 
study reported this. There was indeterminate evidence of measurement error for the PEPPI-5 191 
[21] (limits of agreement -6.83 to 6.35) because the MIC was not defined (see Appendix 2). 192 
 193 
Structural Validity 194 
To demonstrate adequate structural validity, the factors identified should explain at least 50% 195 
of the variability of responses (see Appendix 2). There was strong evidence (excellent rating) 196 
that the PEPPI-5 featured an appropriate 1-factor structure [21]. There was moderate evidence 197 
(good rating) that the PEPPI-10 demonstrated a two factor structure [23]. There was limited 198 
evidence (fair rating) of positive structural validity for the PAM [16] and limited evidence (fair 199 
rating) that the factor structure of the SCQOA did not explain 50% of the variance [17] . There 200 
was also limited evidence (fair rating) of a negative result for structural validity of the ENAT 201 
[20]. The level of evidence for the structural validity of the EC-17, MHLC and PBC [18, 19, 22] 202 
was indeterminate (poor rating).  203 
 204 
Hypothesis Testing 205 
The demonstration of adequate construct validity through hypothesis testing required that 206 
specific hypotheses were formulated a priori AND at least 75% of the results were in 207 
accordance with these [15]. There was limited evidence (fair rating) for adequate construct 208 
validity for the PEPPI-5 [21] which was evaluated against; General Self Efficacy scale, Arthritis 209 
Impact Measurement Scales 2 Family and Friends scale, Short Form 36 mental component 210 
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summary score, and pain numerical rating score. The EC-17 was compared with the same 211 
instruments as the PEPPI-5, however there was indeterminate evidence (poor rating) for the 212 
hypotheses tested (see Table 4) [22] . The study assessing PEPPI-10 did not formulate a priori 213 
hypotheses therefore the evidence for hypotheses testing was indeterminate [23]. 214 
 215 
Cross-cultural Validity 216 
Cross-cultural validity is established following specified translation procedures, then 217 
comparison of two cohorts differing only in language/cultural background to test if the 218 
translated instrument accurately reflects the measurements made in the original [12]. There 219 
was limited evidence (fair rating) for adequate translation of the English PAM[24] into Korean 220 
[16]. The Korean PAM was not compared with the English version. There was indeterminate 221 
evidence (poor rating) for the translation of the English EC-17  [25] into Dutch [22] and no 222 
formal cross-cultural validation. There was limited evidence (fair rating) of adequate translation 223 
of the English PEPPI-10 [26] into Chinese [23] with no cross-cultural validation. Cross-cultural 224 
comparisons were not made for the ENAT because the structural validity was inadequate in the 225 
OA group [20].  226 
Floor and ceiling effects 227 
Floor and ceiling effect results were rated using the quality criteria for rating the results of 228 
measurement properties in Appendix 2. There was strong evidence of absence of floor and 229 
ceiling effects for the PEPPI-5 [21], limited evidence of a ceiling effect for the PEPPI-10 [23] and 230 
indeterminate evidence for floor and ceiling effect for the EC-17 [22]. 231 
 232 
Best evidence synthesis 233 
The instrument with the most promising level of evidence for the measurement properties 234 
available was the PEPPI-5. Of note is that these results are applicable only to the Dutch 235 
language version of the PEPPI-5. There was strong evidence for internal consistency, structural 236 
validity, and lack of floor/ceiling effects, however there was limited positive evidence for 237 
construct validity (hypothesis testing) and limited evidence of negative findings for test-retest 238 
reliability (Tables 6 and 7). There was indeterminate evidence for measurement error and no 239 
information for content validity, or responsiveness. 240 
Discussion 241 
Osteoarthritis self-management programmes are not curative, but aim to equip participants 242 
with the tools to manage their disease. It is important to measure the changes in attitudes 243 
towards and/or capabilities regarding OA self-management to determine whether participants 244 
achieve this aim and to demonstrate efficacy of programmes. Further, it may be possible to 245 
predict outcomes of participants by measuring attitudes towards and/or capabilities in regards 246 
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 8 
to OA self-management at baseline. This may provide a basis on which to appropriately allocate 247 
healthcare resources to those that will likely benefit from such a programme. Participants 248 
reporting a positive attitude toward self-management and good self-management capabilities 249 
may be prioritised for immediate engagement in a programme. Conversely, individuals 250 
reporting poorer attitudes and capabilities may be targeted for supplementary therapies such 251 
as motivational coaching to improve the likelihood of successful participation in such a 252 
programme. In order to test whether this is possible, we first need to identify a suitable 253 
instrument measuring attitudes towards and/or abilities regarding self-management of OA that 254 
demonstrates good measurement properties. 255 
This systematic review is the first to synthesize the measurement property evidence for 256 
instruments assessing attitudes towards and/or capabilities regarding self-management of OA. 257 
There were a very small number of studies identified; only eight studies reported measurement 258 
properties of such instruments, each for a separate instrument. The scope of measurement 259 
properties assessed by the included studies was very limited. Internal consistency and 260 
structural validity was estimated for all instruments. Test-retest reliability [21, 22], and 261 
hypothesis testing [21, 22] were each assessed for two instruments, cross-cultural validity was 262 
addressed in three studies [16, 22, 23] . Measurement error was reported in one study [21], 263 
responsiveness and content validity were not evaluated for any of the instruments.  264 
Given the limited measurement property evidence for the included instruments we cannot 265 
provide a definitive, evidence-based recommendation for a particular instrument to measure 266 
attitudes towards and capabilities regarding OA self-management on the basis of good 267 
measurement properties. On balance, the instrument with the “best” measurement properties 268 
was the Dutch version of the PEPPI-5 [21]. There was strong evidence that the PEPPI-5 satisfied 269 
requirements for internal consistency and structural validity. There was limited evidence for the 270 
hypotheses specified comparing PEPPI-5 scores against several other PROMs. The test-retest 271 
reliability findings were sub-optimal (i.e. ICC<0.7) which has implications regarding the standard 272 
error of the measure. Greater standard error may require larger change scores to represent 273 
‘real’ change (vs error inherent in the measure) between groups over time. The evidence for 274 
measurement error of the PEPPI-5 was indeterminate because the MIC was not provided. 275 
Measurement property evidence for content validity and responsiveness of the PEPPI-5 276 
remains unknown. The remaining instruments identified in the review demonstrated moderate 277 
evidence of positive measurement properties at best.  278 
The PEPPI-5 was originally developed in a sample of “older people” with mixed medical 279 
diagnoses; measurement property results for internal consistency, structural and construct 280 
validity were reported for this population [26]. Given the PEPPI-5 was developed for a different 281 
group of patients it may be that it has limited content validity for OA. The PEPPI-5 measures 282 
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self-efficacy in obtaining both medical information and attention to chief health concern from a 283 
physician, hence includes limited aspects of a patient’s ability to self-manage OA. Although 284 
effective communication with a physician is important, it may not be a key outcome used to 285 
indicate the efficacy of such programmes. OA self-management programmes are often 286 
multidisciplinary, with input from a team of health professionals including physiotherapists, 287 
dietitians and occupational therapists [27], and some programmes do not include a medical 288 
physician [28]. Hence, there is a clear need to develop tools that have adequate content validity 289 
for participants of OA self-management programmes. 290 
A previous systematic review synthesized the measurement property evidence for instruments 291 
measuring self-efficacy in participants with rheumatic conditions [29]. Self-efficacy is defined as 292 
the confidence that one possesses the ability to influence events that affect aspects of one’s life 293 
[30]. Self-efficacy is potentially an important aspect of self-management,  however additional 294 
constructs may be considered such as how motivated or activated participants are to self-295 
manage [24], or beliefs about who controls their health [18].  296 
The previous review included participants of mixed disease groups with different rheumatic 297 
conditions [29]. Given that measurement property evidence is specific to the population 298 
studied, these measurement property results cannot be extrapolated to the OA population. The 299 
population-specific nature of measurement properties also placed limitations on the studies 300 
available for this current review. Often studies were excluded at the full-text stage because 301 
they comprised mixed disease cohorts and did not report the OA participant results separately. 302 
This limited the number of studies included.  303 
The methodologies of the included studies were limited to investigation of a small range of 304 
measurement properties. Internal consistency and structural validity were reported for all 305 
studies. This is similar finding to the previous systematic review of self-efficacy in patients with 306 
rheumatic conditions [29]. Although these are valuable measurement properties to establish, 307 
many measurement properties remain untested in the instruments of our systematic review. 308 
Test-retest reliability estimates the relative consistency of a measure in otherwise stable 309 
patients, so that when any change is detected by the instrument, it can be attributed to the 310 
intervention rather than from measurement error of the instrument. Unfortunately the test-311 
retest reliability and measurement error for the included instruments are yet to be established 312 
in OA patients. Test-retest reliability was tested in a larger proportion of studies included in the 313 
systematic review on rheumatic conditions, however the quality of the evidence was generally 314 
poor and measurement error was unreported [29]. Hypothesis testing is a further property that 315 
was neglected by the majority of studies in our review. Hypothesis testing establishes whether 316 
an instrument measures the intended construct by testing the internal relationships with scores 317 
of other instruments measuring similar or different constructs [13]. There is much need for 318 
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future studies evaluating test-retest reliability, measurement error and construct validity of 319 
instruments measuring OA self-management attitudes and capabilities. 320 
 Cross-cultural validation was attempted in three studies that translated questionnaires; 321 
however, true cross-cultural validation comparing language versions was not conducted. This 322 
was also found in the previous review of instruments measuring self-efficacy [29]. We found no 323 
evidence pertaining to content validity, responsiveness, or MID/MIC. Similar to previous 324 
conclusions [29], the recommendations arising from the present review are limited due to the 325 
small number of studies, their poor methodology, and the limited scope of measurement 326 
properties assessed. Further studies concerned with all measurement properties of existing 327 
instruments assessing self-management of OA is the only way to remedy this situation. 328 
Some existing instruments measuring attitudes towards and/or capabilities regarding OA self-329 
management were not featured in the systematic review because there was no measurement 330 
property evidence available. The Health Education Impact Questionnaire (heiQ) [31] evaluates 331 
the efficacy of patient education programs and has been used to evaluate OA self-management 332 
programs [5, 32]. Also, the Arthritis Self Efficacy Score (ASES) measures patients’ perceived self-333 
efficacy to cope with the symptoms and limitations attributed to chronic arthritis [33] and is a 334 
published outcome of existing OA self-management programs [34, 35]. The measurement 335 
properties of the heiQ and ASES remain untested in the OA population. Given the current 336 
popularity of these instruments, the measurement properties of heiQ and ASES are an 337 
important area of future research. 338 
There were possible limitations of this systematic review; the inclusion criteria requiring studies 339 
to be published as original articles may have introduced publication bias. Unpublished studies 340 
may have been more likely to contain evidence of negative results about measurement 341 
properties of the instruments under study. However, the inclusion of only peer-reviewed 342 
articles likely enhanced the quality of included studies, given the basic level of scrutiny required 343 
to publish. This may have improved the quality of the review rather than biasing it. While 344 
excluding non-English language studies may have introduced bias, no such studies were 345 
identified by the comprehensive search strategy. 346 
Conclusion 347 
This review highlights the paucity of evidence available for the measurement properties of 348 
instruments assessing attitudes towards and/or capabilities regarding OA self-management. 349 
There were many gaps in the measurement property evidence for the instruments identified. 350 
The instrument with the “best” properties assessed self-efficacy in communication with a 351 
physician; a very discrete aspect of self-management. Therefore, we were unable to make 352 
recommendations concerning instruments to assess attitudes toward and/or capabilities 353 
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regarding OA self-management. Further well-designed studies of measurement properties of 354 
available instruments are required. This review may provide a starting point for researchers to 355 
identify the instruments that are currently used for this purpose in the OA population and the 356 
evidence for measurement properties available. Once we are able to identify instruments with 357 
adequate measurement properties for use in this population, we will be able to better compare 358 
the efficacy of different OA self-management programmes and inform best practice for care of 359 
our patients. 360 
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Appendix 1. Search strategy 
i) Construct 
generalized self efficacy scale[tiab] OR adaptive behavior[tiab] OR multidimensional health 
locus of control[tiab] OR pain self efficacy questionnaire[tiab] OR health literacy 
management scale[tiab] OR stages of change questionnaire in osteoarthritis[tiab] OR health 
education impact questionnaire[tiab] OR patient activation measure[tiab] OR effective 
consumer scale[tiab] OR arthritis self-efficacy scale[tiab] OR internal-external control[MH] 
OR locus of control[tw] OR attitude to health[MH] OR health locus of control[tiab] OR 
adaptation, psychological[MH] OR health behavior[MH] OR health knowledge, attitudes, 
practice[MH] OR self management behavio*[tiab] OR patient activation[tiab] OR self 
concept[MH] OR self efficacy[MH] OR confidence[tiab] OR activation[tiab] OR consumer 
participation[MH] OR patient education as topic[MH] OR Patient Participation[MH] OR 
individualized medicine[MH] OR patient-centered care[MH] OR goals[MH] OR patient 
preference[MH] OR choice behavior[MH] OR decision making[MH] OR patient care 
planning[MH] OR personalised care planning[tiab] OR patient led[tiab] OR 
selftreatment[tiab] OR self treat*[tiab] OR self manage*[tiab] OR self care[tiab] OR self 
care[MH] 
 
ii) Target population  
osteoarthritis[MH] OR osteoarth*[tiab] OR degenerative arthritis[tiab] OR arthrosis[tiab] 
iii) Measurement instrument filter 
instrumentation[sh] OR methods[sh] OR validation studies[pt] OR Comparative Study[pt] OR 
psychometrics[MH] OR psychometr*[tiab] OR clinimetr*[tw] OR clinometr*[tw] OR 
“outcome assessment (health care)”[MH] OR “outcome assessment”[tiab] OR “outcome 
measure*”[tw] OR “observer variation”[MH] OR “observer variation”[tiab] OR “Health 
Status Indicators”[MH] OR “reproducibility of results”[MH] OR reproducib*[tiab] OR 
“discriminant analysis”[MH] OR reliab*[tiab] OR unreliab*[tiab] OR valid*[tiab] OR 
coefficient[tiab] OR homogeneity[tiab] OR homogeneous[tiab] OR “internal 
consistency”[tiab] OR (cronbach*[tiab] AND (alpha[tiab] OR alphas[tiab])) OR (item[tiab] 
AND (correlation*[tiab] OR selection*[tiab] OR reduction*[tiab])) OR agreement[tiab] OR 
precision[tiab] OR imprecision[tiab] OR “precise values”[tiab] OR test–retest[tiab] OR 
(test[tiab] AND retest[tiab]) OR (reliab*[tiab] AND (test[tiab] OR retest[tiab])) OR 
stability[tiab] OR interrater[tiab] OR inter-rater[tiab] OR intrarater[tiab] OR intra-rater[tiab] 
OR intertester[tiab] OR inter-tester[tiab] OR intratester[tiab] OR intra-tester[tiab] OR 
interobserver[tiab] OR inter-observer[tiab] OR intraobserver[tiab] OR intraobserver[tiab] OR 
intertechnician[tiab] OR inter-technician[tiab] OR intratechnician[tiab] OR intra-
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technician[tiab] OR interexaminer[tiab] OR inter-examiner[tiab] OR intraexaminer[tiab] OR 
intra-examiner[tiab] OR interassay[tiab] OR inter-assay[tiab] OR intraassay[tiab] OR intra-
assay[tiab] OR interindividual[tiab] OR inter-individual[tiab] OR intraindividual[tiab] OR 
intra-individual[tiab] OR interparticipant[tiab] OR inter-participant[tiab] OR 
intraparticipant[tiab] OR intra-participant[tiab] OR kappa[tiab] OR kappa’s[tiab] OR 
kappas[tiab] OR repeatab*[tiab] OR ((replicab*[tiab] OR repeated[tiab]) AND (measure[tiab] 
OR measures[tiab] OR findings[tiab] OR result[tiab] OR results[tiab] OR test[tiab] OR 
tests[tiab])) OR generaliza*[tiab] OR generalisa*[tiab] OR concordance[tiab] OR 
(intraclass[tiab] AND correlation*[tiab]) OR discriminative[tiab] OR “known group”[tiab] OR 
factor analysis[tiab] OR factor analyses[tiab] OR dimension*[tiab] OR subscale*[tiab] OR 
(multitrait[tiab] AND scaling[tiab] AND (analysis[tiab] OR analyses[tiab])) OR item 
discriminant[tiab] OR interscale correlation*[tiab] OR error[tiab] OR errors[tiab] OR 
“individual variability”[tiab] OR (variability[tiab] AND (analysis[tiab] OR values[tiab])) OR 
(uncertainty[tiab] AND (measurement[tiab] OR measuring[tiab])) OR “standard error of 
measurement”[tiab] OR sensitiv*[tiab] OR responsive*[tiab] OR ((minimal[tiab] OR 
minimally[tiab] OR clinical[tiab] OR clinically[tiab]) AND (important[tiab] OR significant[tiab] 
OR detectable[tiab]) AND (change[tiab] OR difference[tiab])) OR (small*[tiab] AND 
(real[tiab] OR detectable[tiab]) AND (change[tiab] OR difference[tiab])) OR meaningful 
change[tiab] OR “ceiling effect”[tiab] OR “floor effect”[tiab] OR “Item response model”[tiab] 
OR IRT[tiab] OR Rasch[tiab] OR “Differential item functioning”[tiab] OR DIF[tiab] OR 
“computer adaptive testing”[tiab] OR “item bank”[tiab] OR “cross-cultural 
equivalence”[tiab] 
iv) Exclusion filter 
“addresses”[PT] OR “biography”[PT] OR “case reports”[PT] OR “comment”[PT] OR 
“directory”[PT] OR “editorial”[PT] OR “festschrift”[PT] OR “interview”[PT] OR “lectures”[PT] 
OR ”legal cases”[PT] OR “legislation”[PT] OR “letter”[PT] OR “news”[PT] OR “newspaper 
article”[PT] OR “patient education handout”[PT] OR “popular works”[PT] OR 
“congresses”[PT] OR “consensus development conference”[PT] OR “consensus 
development conference, nih”[PT] OR “practice guideline”[Publication Type]) NOT 
("animals"[MeSH Terms] NOT "humans"[MeSH Terms] 
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Appendix 2: Quality criteria for rating the results of measurement properties  
 
Measurement 
property 
Rating Quality criteria 
Internal Consistency + 
 
 
? 
- 
 
0 
Factor analyses performed on adequate sample size (7 * # items and 
>100) AND Cronbach’s alpha(s) calculated per dimension AND 
Cronbach’s alpha(s) between 0.70 and 0.95 
No factor analysis OR doubtful design or method 
Cronbach’s alpha(s) ≤ 0.70 or ≥ 0.95, despite adequate design and 
method 
No information found on internal consistency 
Reliability + 
? 
- 
0 
ICC or weighted Kappa > 0.70 
Doubtful design or method (e.g., time interval not mentioned) 
ICC or weighted Kappa < 0.70, despite adequate design and method 
No information found on reliability 
Measurement error + 
? 
- 
0 
MIC > SDC OR MIC outside the LOA 
MIC not defined or doubtful design 
MIC < SDC OR MIC equals or inside LOA 
No information found on measurement error 
Structural validity + 
? 
- 
0 
Factors should explain at least 50% of the variance 
Explained variance not mentioned 
Factors explain <50% of the variance 
No information found on structural validity 
Hypothesis testing + 
 
? 
- 
 
0 
Specific hypotheses were formulated AND at least 75% of the results 
are in accordance with these hypotheses 
Doubtful design or method (e.g., no hypotheses) 
Less than 75% of hypotheses were confirmed, despite adequate 
design and methods 
No information found on hypothesis testing 
Cross-cultural validity + 
 
? 
- 
 
0 
Original factor structure confirmed or no important DIF found 
between language versions 
Confirmatory factor analysis not applied & DIF not assessed 
Original factor structure not confirmed or important DIF found 
between language versions 
No information found on cross-cultural validity 
Floor and ceiling 
effects 
+ 
 
? 
- 
 
0 
≤15% of the respondents achieved the highest or lowest possible 
scores 
Doubtful design or method 
>15% of the respondents achieved the highest or lowest possible 
scores despite adequate design and methods 
No information found on interpretation 
Adapted from Terwee et al J Clin Epidemiol 2007; 60(1): 34-42. and F. Dobson et al. Osteoarthritis and 
Cartilage 20 (2012) 1548-1562. Content and criterion validity, responsiveness, & interpretability were 
not reported on in any included studies; hence have been omitted.  
ICC= intraclass correlation coefficient, LOA= limits of agreement, MIC= minimal important change, SDC= 
smallest detectable change 
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Table 1. Definitions of measurement properties  
Definitions adapted from Mokkink et al J Clin Epidem 36 (2010) and de Vet, H., et al., “Measurement in Medicine: A Practical Guide 
to Biostatistics and Epidemiology” (2010). 
Measurement property Definition 
 
Internal consistency The degree to which items of an instrument are related to each other  
 
Reliability The proportion of the total variance of  “true differences” measured by 
the instrument that is not attributed to measurement error 
 
Measurement error 
  
The component of a patient’s score that is not due to real changes  of 
the construct measured by the instrument, but attributed to 
systematic and/or random error 
Content validity The degree to which the content of the instrument measures the 
construct it intends to measure  
 
Structural validity The extent to which the scores of an instrument conform to the 
dimensionality of the construct intended  
 
Hypotheses testing An aspect of construct validity; when questions are formulated a priori 
about the expected relationships with instruments measuring related 
constructs  
 
Cross-cultural validity The extent to which the translated or culturally adapted instrument 
reflects  the performance of  the original version of the instrument  
 
Criterion validity When the scores of an instrument are compared to determine if they 
are reflective of the outcomes of another instrument considered to be 
the “gold standard”  
 
Responsiveness 
 
The measurement of the ability of the instrument to detect changes in 
scores that reflect change in the construct over time  
Floor and ceiling effects 
 
The proportion of participants who responded with the lowest or 
highest possible score on the instrument 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
 
Table 2. Levels of evidence for the quality of the measurement property 
Adapted from Terwee et al. J Clin Epidemiol 2007;60(1):34-42  
+ = positive rating, ? =  unknown rating, - = negative rating. 
 
Level of evidence Rating Criteria 
Strong +++ OR --- Consistent ﬁndings in multiple studies of good 
methodological quality OR in one study of excellent 
methodological quality 
 
Moderate ++   OR -- Consistent ﬁndings in multiple studies of fair methodological 
quality OR in one study of good 
methodological quality 
 
Limited +     OR - One study of fair methodological quality 
 
Conflicting ± Conﬂicting ﬁndings 
 
Indeterminate ? Only studies of poor methodological quality 
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Table 3. Content comparison of instruments measuring self-rated attitudes towards and capabilities to self-manage osteoarthritis 
 
MHLC= Multidimensional Health Locus of Control, IHLC= Internal Health Locus of control, PBC= Perceived behavioural control, PAM13= Patient 
activation measure, ENAT= Educational needs assessment, PEPPI-5= Perceived Efficacy in Patient–Physician Interactions Scale, SCQOA= The 
Stages of Change Questionnaire in Osteoarthritis, EC-17= Effective Consumer Scale. 
 
 
 
 
Construct 
Attitudes/beliefs 
pertaining to 
self-
management of 
OA  
Attitudes/beliefs 
pertaining to 
changing health 
behaviour 
Knowledge 
required for 
self-
management 
 
Capability to 
perform skills 
required for 
self-
management  
Educational 
needs for self-
management 
of OA 
Interactions 
with health 
care providers 
assisting with 
management 
of OA  
 
 
Overall 
capability to 
self-manage 
OA  
MHLC
18 
 
•        
PBC
19 
 
•    •   •   
PAM-13
16 
 
•   •  •   •  •  
ENAT
20 
 
•  •  •   •    
PEPPI-5
21 
 
  •  •   •   
SCQOA
17 
 
•  •       
EC-17
22 
 
•   •  •   •   
PEPPI-10
23 
 
 
 •  •   •   
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Table 4. Characteristics of included studies of instruments measuring attitudes toward and/or capabilities regarding self-
management of OA 
MHLC= Multidimensional Health Locus of Control, IHLC= Internal Health Locus of control, PHLC= Powerful Others Health Locus of control, CHLC= 
Chance Health Locus of Control, PBC= Perceived behavioural control, PDP= Perceived diﬃculty for physicians, PDPh= Perceived diﬃculty for 
pharmacists, SEP= Self-eﬃcacy for physicians, SEPh= Self-eﬃcacy for pharmacists, CP= Controllability for physicians, CPh= Controllability for 
pharmacists, PAM13= Patient activation measure, ENAT= Educational needs assessment, PEPPI-5= Perceived Efficacy in Patient–Physician 
Interactions scale, SCQOA= The Stages of Change Questionnaire in Osteoarthritis, EC-17= Effective Consumer Scale. RA: Rheumatoid arthritis, 
FM: Fibromyalgia, AS: Ankylosing spondylitis, PsA: Psoriatic arthritis, SLE: Systemic Lupus Erythematosus, SS: Systemic sclerosis,  
Authors/ 
Instru-
ment 
 
Construct 
described  
Time to 
administer 
Availability Language 
& country 
Number, type of 
questions & scoring 
Proport 
-ion 
with OA 
(%) 
OA site 
& stage 
% other 
diseases 
in sample 
N with > 
80% OA 
(response 
rate 
%) 
Age: mean age 
years (SD) or 
age groups (%) 
Female 
% 
Mean (standard 
devation), 
possible score 
range, 
distribution 
Kelly  
(2007)/ 
MHLC
18 
Measures 
beliefs about 
who or what 
controls the 
patient’s health 
status 
Not stated Freely 
available at: 
http://www
.nursing.van
derbilt.edu/
faculty/kwal
lston/mhlcs
cales.htm 
 
English, 
USA & 
Canada 
Three scales of 6 items 
each, using 6-point likert 
scale measuring the 
following dimensions: 
‘‘Internal’’ ‘‘Chance’’ and 
‘‘Powerful Others’’.  
Sum the individual item 
scores for each subscale. 
86.2 Hip & 
knee 
Control 
sample: 
13.8 
1040 (100) Study I: 65 (9) 
Study II: 64 (16) 
Study III: 62 (6) 
Study I:  
(66) 
Study II:  
(59) 
Study 
III: (63) 
IHLC: 26.44 
(5.61) 
PHLC: 20.22 
(6.64) 
CHLC: 16.96 
(6.05) 
Each subscale 
has range 6- 36 
Liu 
(2007)/ 
PBC 
19 
Survey of OA 
patients' drug 
information 
seeking from 
physicians and 
pharmacists. 
Not stated In published 
paper 
English 
USA 
8 statements with 7-point 
likert responses 
Perceived difficulty:3 
Self-efficacy: 3 
Controllability: 2 
Answer for physicians & 
pharmacists separately  
 
100 Not 
stated 
- 1000 (61.9) 18-24: 1.8% 
25-34: 3.8% 
35-44: 11.9% 
45-54: 27.6% 
55-64: 28.3% 
>64:  26.6% 
72.8 PDP: 5.10 (1.60) 
PDPh: 5.27 
(1.49) 
SEP: 5.62 (1.62) 
SEPh: 5.62 (1.60) 
CP: 5.63 (1.36)       
CPh: 5.62 (1.37) 
 
Ahn 
(2015)/ 
PAM-13
16 
Patient 
activation: 
patient’s 
knowledge, 
skill, and 
confidence 
Not stated Insignia 
Health 
provides 
licenses for 
the PAM at 
a cost 
Korean, 
South 
Korea 
13-statements, with 
responses on a 4-point 
likert scale. Raw score: 
sum responses to the 13 
items. Scores ranging 
from 13 to 52. converted 
100 Not 
stated 
- 270 (100) 72.2 (8.3) 82.4 50.0 (13.5)  0-
100, 
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regarding the 
self- 
management of 
a chronic 
disease 
 
to a 0–100 interval scale. 
Higher total PAM scores 
reflect higher levels of 
patient activation. 
 
Ndosi 
(2014)/ 
ENAT
20 
Assesses the 
educational 
needs 
(priorities) of 
patients with 
rheumatic 
diseases 
Not stated Contact 
authors 
Austrian 
German 
Finnish 
Dutch 
Norwei-
gian 
Portu-
guese 
Spanish 
Swedish 
Austria 
Finland 
Nether-
lands 
Norway 
Portugal 
Spain 
Sweden 
 
39 items with 4-point 
likert scale in 7 domains: 
managing pain (6 items), 
movement 
(5 items), feelings (4 
items), arthritis process 
(7 items), treatments (7 
items), self-help 
measures 
(6 items) and support 
systems (4 items) 
14.4 Hand, 
hip or 
knee in 
discussi
on. 
Stage 
not 
stated 
AS: 22.5% 
FM:  12% 
PsA: 
26.8% 
SLE:  
12.3% 
SS:  12.0% 
433 
(response 
rate not 
stated) 
Not stated for 
OA sample: 
pooled sample 
is 52.6(13.1) 
Not 
stated 
for OA 
but 
across 
pooled 
sample 
66.2 
Not stated for 
OA group 
ten 
Klooster 
(2012)/ 
PEPPI-5
21 
Self-efficacy in 
both obtaining 
medical 
information and 
attention to 
chief health 
concern from a 
physician 
Not stated Dutch 
version 
freely 
available on 
web. English 
version 
published 
Dutch, 
Nether-
lands 
5 questions with 
responses on a 5-point 
numerical rating scale. 
Total scores are summed 
to range from 5 to 25, 
higher total scores reflect 
higher perceived self-
efficacy in patient–
physician interactions. 
100 Not 
stated 
- 224 (55.4) 62.9 (10.2) 81.3 18.8 (4.3) 
5- 25, 
Slightly 
negatively 
skewed. 
Heuts 
(2005)/ 
SCQOA
17 
People move 
from low to 
high level of 
participation. 
Stages:  no 
intention to 
change to 
optimal 
3-5 min Published in 
paper as 
appendix (in 
English) 
Unclear 
(Dutch or 
English), 
Nether-
lands 
21 items scored on 5-
point likert scale. 
3 subscales: 7 questions 
for precontemplation, 7 
for contemplation, 7 for 
action. 
100 In 
results 
hip, 
knee & 
hand. 
Stage 
not 
stated 
- 273 (100) Range 40-60 
years for 
inclusion 
criteria 
59.7 Using highest 
score method: 
10.3% was in the 
'pre-
contemplation 
stage', 22.3% in 
the 
'contemplation 
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active 
participation 
with 
internalization 
of new behavior 
 
stage', 67.0% 
was 'in action', 
ten 
Klooster 
(2013)/ 
EC-17
22 
Measures 
knowledge, 
attitudes, and 
behaviours 
regarding self-
management 
skills 
Not stated Available in 
published 
paper & on 
web 
http://www
.cgh.uottaw
a.ca/assets/
documents/
Survey.pdf 
Dutch 
Nether-
lands 
17 items with 5-point 
Likert scale. Item scores 
are summed when  items 
are completed and 
converted to range from 
0 to 100, where 100 is the 
best possible score. 
 
85.6 Not 
stated 
FM: 14.4 209 (55.8% 
of 
combined 
OA & FM 
sample) 
62.6 (10.1) 80.9 68.9 (16.3), 
0-100, 
Near normal 
distribution 
(Kolmogorov-
Smirnov, P= 
0.058) 
 
Zhao 
(2016) 
PEPPI-
10
23 
 
Self-efficacy in 
both obtaining 
medical 
information and 
attention to 
chief health 
concern from a 
physician 
Not stated Supplement 
link from 
paper:  
https://ww
w.dovepres
s.com/get_s
upplementa
ry_file.php?
f=110883.p
df 
Chinese, 
China 
10 items with 10 point 
Numerical Rating Scale: 
Not confident to 
extremely confident. Sum 
ten scores from 0 to 100 
(100 best self-efficacy) 
100 Knee - 115 (100) 63.42 (6.7) 59 90.07 ( 12.9), 
0- 100 
Negatively 
skewed 
distribution 
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Table 5. Measurement properties instruments measuring self-management of OA according to the COSMIN checklist with 4-point 
scale: internal consistency, reliability, measurement error and structural validity. 
NOTE:  Content validity, criterion validity and responsiveness were not reported on in any included articles, hence do not appear in the table. 
#
This field was only completed for those instruments based on Item Response Theory (IRT). 
MHLC= Multidimensional Health Locus of Control, IHLC= Internal Health Locus of control, PHLC= Powerful Others Health Locus of control, CHLC= Chance Health Locus of Control, 
PBC= Perceived behavioural control, PDP= Perceived diﬃculty for physicians, PDPh= Perceived diﬃculty for pharmacists, SEP= Self-eﬃcacy for physicians, SEPh= Self-eﬃcacy for 
pharmacists, CP= Controllability for physicians, CPh= Controllability for pharmacists, PAM13= Patient activation measure, ENAT= Educational needs assessment, PEPPI-5= 
Perceived Efficacy in Patient–Physician Interactions 5 item scale, SCQOA= The Stages of Change Questionnaire in Osteoarthritis, EC-17= Effective Consumer Scale. FA= Factor 
Analysis, PCA= Principal Components Analysis, GFI= Goodness of fit index, MNSQ= Infit & outfit mean square statistics, NRS= numerical rating score, NS= non-significant, NNFI= 
Non-normed Fit Index, CFI= comparative fit index, SRMR= standardized root mean square residual, RMSEA=  root mean square error of approximation,  SB χ
2
= Satorra-Bentler 
chi-squared statistic, LOA = limits of agreement, MFES= modified fall efficacy scale, OSES= osteoporosis self-efficacy scale, PEPPI-10= Perceived Efficacy in Patient–Physician 
Interactions 10 item  scale; SEE-C= self-efficacy for exercise scale. 
 
Instrument 
#
Requirements  
IRT  
Internal consistency Reliability Measurement error Structural validity 
 
 
Result 
Cronbach’s alpha 
COSMIN 
score 
Result COSMIN 
score 
Result COSMIN 
score 
Result COSMIN 
score 
MHLC
18 
 
Good IHLC: 0.75; PHLC: 
0.70; CHLC: 0.65 
Poor - - - - Confirmatory FA, 3 factor 
model: χ
2
= 904.50 , 135 df, 
(P<0.01), RMSEA 0.0, GFI = 
0.96, CFI=  0.79, ECVI= 
0.81,PCA, FA & Rasch 
analysis supported  item 
reduction: removed 2 
items  
Poor 
PBC
19 
 
- PDP: α= 0.77 
PDPh: α= 0.72 
SEP:α= 0.83 
SEPh: α= 0.83 
 
Fair - - - - PCA & exploratory FA with 
Factor loading.  
Data reduction & data 
detection 
Fair 
PAM-13
16 
 
Good α= 0.88 Fair - - - - Confirmatory PCA 
GFI= 32 (11.9%) misfits 
MNSQ 0.68 to 1.42 
Rasch analysis: person 
reliability was between .87 
(real) and .89 (model), and 
Fair 
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the item reliability was 
.99. The separation index 
for persons was 2.57 and 
that for items was 10.56. 
57.5% variance of data 
explained. 
 
ENAT
20 
 
Good IRT: Person 
separation index 
> 0.9 
 
Poor - - - - Confirmatory FA, structure 
detection & 
Rasch analysis 
OA group was a misfit 
 
Fair 
PEPPI-5
21 
 
- α= 0.92 Excellent Test-retest: 
ICC 0.68 (95% CI 
0.56, 0.78) 
Bland–Altman 
analysis LOA 6.83 
-6.35 (mean 
difference  -0.24, 
t(99) = - 0.71, p = 
0.48) 
Fair LOA -6.83-  6.35 
differences _ 
weakly related 
to the  
magnitude of 
the 
measurement 
(r2 = 0.04, p = 
0.049), 
indicating 
little to no 
systematic bias. 
Fair Confirmatory FA, factor 
loading & structure 
detection (1 factor) 
SB χ
2
 (5) = 17.43, NNFI = 
0.98, CFI = 0.99, 
SRMR = 0.03, RMSEA (90% 
CI) = 0.11 (0.05–0.16) 
Excellent 
SCQOA
17 
 
- action α= 0.74 
precontemplation 
α= 0.70 
contemplator α= 
0.77 
After removal of 5 
items: 
action α= 0.79  
precontemplation 
α= 0.72 
contemplation α= 
0.76 
 
Fair - - - - Confirmatory FA, factor 
loading & date reduction: 
removal of items 3, 7, 12, 
16, 18 and 20 
PCA. 
Repeated FA with 15 item 
scale: 3 factors explained 
45% of variance 
 
Fair 
EC-17
22 
Good person reliability:  Poor test-retest Poor - - Confirmatory FA Poor 
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0.92 ICC= 0.71 (95 % 
CI: 0.60–0.80) 
Apart from RMSEA, 1-
factor model 
good fit  
SB χ
2
 (119) = 488.70,  
NNFI = 0.96, 
CFI = 0.96, SRMR = 0.08, 
RMSEA (90 % CI) = 0.11 
(0.10–0.12). 
PEPPI-10
23 
- α= 0.91 Good - - - - Confirmatory FA: two-
factor model good fit 
(df=33, P-value =0.000) 
except  RMSEA=0.164 
above cutoff 
Good 
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Table 6. Measurement properties of instruments measuring self-management: construct validity, cross-cultural validity, and floor 
and ceiling effects. 
NOTE:  Content validity, criterion validity and responsiveness were not reported on in any included articles, hence do not appear in the table.  Floor and ceiling
 
effects were not 
evaluated using the COSMIN Checklist. 
*
Paper did not assess cross-cultural validity however did translate the questionnaire into other language(s) hence quality of translation items of COSMIN checklist were rated 
(Box G items 4-11). 
MHLC= Multidimensional Health Locus of Control, IHLC= Internal Health Locus of control, PBC= Perceived behavioural control, PAM13= Patient activation measure, ENAT= 
Educational needs assessment, PEPPI-5= Perceived Efficacy in Patient–Physician Interactions 5 item scale, SCQOA= The Stages of Change Questionnaire in Osteoarthritis, EC-17= 
Effective Consumer Scale, GSES= General Self Efficacy scale, AIMS2 F & F= Dutch Arthritis Impact Measurement Scales 2 Family and Friends scale, SF-36 MCS= Short form 36 
mental component summary score, SF- 36 PCS=  Short form 36 mental component summary score, MFES= modified fall efficacy scale, OSES= osteoporosis self-efficacy scale, 
PEPPI-10= Perceived Efficacy in Patient–Physician Interactions 10 item  scale; SEE-C= self-efficacy for exercise scale. 
 
Instrument Construct validity (Hypothesis testing) 
 
Cross-cultural validity 
 
 Floor & ceiling effects 
 Hypothesis Result COSMIN 
score 
Result COSMIN 
score 
Result 
MHLC
18 
 
- - - - -  Seven items, including all six 
items of the IHLC scale, 
exhibited skewness that 
exceeded -1.00 (i.e., a ‘‘ceiling 
effect’’). No floor effect. 
PBC
19 
 
- - - - - - 
PAM-13
16 
 
- - - Items 1 and 4 were adjusted 
to make more sense in 
Korean translation. PCA 
indicated unidimensionality 
 
Fair
* 
- 
ENAT
20 
 
- - - - - - 
PEPPI-5
21 
 
Expected correlations: 
Strongly positively correlated 
with EC-17, moderately 
positively with GSES, weakly 
positively with AIMS2 family & 
friends scale and SF-36 MCS 
and not correlated with SF- 36 
EC-17: r=0.52, p<0.01 
GSES: r= 0.07 (not sig) 
AIMS2 F & F: r=0.23, p<0.05 
SF-36 MCS: R= 0.26, p<0.01 
SF- 36 PCS: r= 0.05 (NS) 
Pain NRS: r=-0.12 (NS) 
 
Fair - - No floor and ceiling effects:  
no patients scored five and 26 
patients (11.6%) scored 25. 
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PCS and pain NRS   
 
SCQOA
17 
 
- - - - - - 
EC-17
22 
Expected correlations: 
Strongly correlated PEPPI-5, 
moderately correlated  GSES 
and AIMS2 F & f, moderate 
correlation  SF-36 MCS, weak 
correlations SF-36 PCS & pain 
NRS 
PEPPI-5: r=0.55, P<0.01, 
GSES: r=0.26, P<0.01 
AIMS2 F & F: r=-0.34, P<0.01 
SF-36 MCS: r=0.39, p<0.01 
SF-36 PCS: r=0.14, p<0.05, 
Pain NRS: r=-0.21, p<0.01 
Poor Following pretests small 
wording changes made in six 
items. CFA supported 
unidimensional structure of 
the scale 
Poor* No ceiling or floor effect 
found: no participants scored 
zero and only 1.3% achieved 
maximum score 
PEPPI-10
23 
No hypothesis and expected 
correlations not stated 
SEE-C: r=0.292, p<0.01, 
MFES: r= 0.220, p<0.05, 
OSES: r=0.315, p<0.01 
Poor Following pretests, two 
items were modified to suit 
Chinese language. FA 
showed Chinese version of 
PEPPI-10 has two common 
factors; different to 1 factor 
reported previously for the 
English version.  
Fair* Ceiling effect found for 28.2% 
of participants. No floor 
effect. 
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Table 7. Summary of the assessment of measurement properties of all instruments using COSMIN rating, quality criteria for rating the results 
of measurement properties and levels of evidence 
NOTE:  Content validity and responsiveness were not reported on in any included studies, hence do not appear in the table.  
*
Paper did not assess cross-cultural validity hence the quality criteria for rating the results of measurement properties (Appendix 2) were not applied to the overall measurement 
property result, however the translation items of COSMIN checklist were rated (Box G items 4-11).   
+++ or --- strong evidence, ++ or -- moderate evidence, + or – limited evidence, ± conflicting evidence, ? indeterminate, 0 no information [+ positive, - negative rating (results)].  
MHLC= Multidimensional Health Locus of Control, IHLC= Internal Health Locus of Control, PBC= Perceived Behavioural Control, PAM13= Patient Activation Measure, ENAT= 
Educational Needs Assessment, PEPPI-5= Perceived Efficacy in Patient–Physician Interactions 5 item Scale, SCQOA= The Stages of Change Questionnaire in Osteoarthritis, EC-17= 
Effective Consumer Scale, PEPPI-10= Perceived Efficacy in Patient–Physician Interactions 10 item Scale  
 
Instrument Internal 
consistency 
Reliability Measurement 
error 
Structural 
validity 
Hypothesis 
testing 
Cross-cultural 
validity 
Floor and 
ceiling effects 
MHLC18 
 
? 0 0 ? 0 0 ? 
PBC
19 
 
+ 0 0 ? 0 0 0 
PAM-13
16 
 
+ 0 0 + 0 *+ 0 
ENAT
20 
 
? 0 0 - 0 0 0 
PEPPI-5
21 
 
+++ - ? +++ + 0 +++ 
SCQOA
17 
 
+ 0 0 - 0 0 0 
EC-17
22 
 
? ? 0 ? ? *? ? 
PEPPI-10
23 
++ 0 0 ++ ? *+ 
 
- 
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  Figure 1. Flowchart of the selection & inclusion of studies 
 
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
  
 
 
Exclusion Criteria  i) Population: proportion of participants with a main diagnosis of OA was less than 80% and the 
results for OA participants were not reported separately 
ii) Construct: Not an instrument that measures attitudes or abilities pertaining to self-
management of OA 
iii) Instrument: Not a patient-reported outcome in form of questionnaire or scale 
iv) Setting: Not used in a clinic setting/field 
v) Measurement study: No primary or secondary aim to examine at least one measurement 
property    
vi) Publication type: Not a full-text article 
vii) Language: Not English (only excluded from COSMIN review) 
Additional full text 
studies assessed for 
eligibility from hand 
searching              
6 
 
PubMed 
4201 references 
Embase 
2136 references 
Cinahl 
190 references 
PsychINFO 
217 references 
Following removal of duplicates 
5653 
 
5653 
Excluded based on 
title/abstract 
5622 
 
 
Full-text articles assessed for eligibility 
31 
Additional full text 
studies from single 
instrument with 
population filter search 
7 
 
 Total included in the review 
8 
Excluded based on full 
text review 
i) 19 
ii) 15 
iii) 0 
iv) 0 
v) 1 
vi) 1 
vii) 0 
 
